Association between PD-L1 variants and PD-L1 expression: A pan-cancer analysis.

被引：0
|
作者：
Wang, Xiang
Zhang, Ding
Wang, Guoqiang
Duan, Anqi
Ruan, Xiang
Zhao, Teng
机构：
[1] Shanghai Eastern Hepatobiliary Surg Hosp, Dept Biliary Tract Surg 2, Mil Med 2, Shanghai, Peoples R China
[2] 3D Med Inc, Med Dept, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13661
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [2] Pan-cancer landscape and impact of PD-L1 and PD-L2 structural variation
    Hoskins, Emily L.
    Samorodnitsky, Eric
    Wing, Michele R.
    Reeser, Julie W.
    Hopkins, Julia
    Murugesan, Karthikeyan
    Kuang, Zheng
    Stein, Leah
    Risch, Zach
    Vella, Raven
    Adebola, Serifat
    Yu, Lianbo
    Paruchuri, Anoosha
    Huang, Richard S.
    Albacker, Lee A.
    Roychowdhury, Sameek
    CANCER RESEARCH, 2022, 82 (12)
  • [3] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar Vs
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    LABORATORY INVESTIGATION, 2016, 96 : 77A - 77A
  • [4] PD-L1 Protein Expression and PD-L1 Gene Amplification in Breast Cancer
    Voronel, Olga
    Dalvi, Siddhartha
    Kallakury, Bhaskar V. S.
    Sheehan, Christine E.
    Boguniewicz, Ann B.
    Ross, Jeffrey S.
    MODERN PATHOLOGY, 2016, 29 : 77A - 77A
  • [5] PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
    Kojima, Kensuke
    Sakamoto, Tetsuki
    Kasai, Takahiko
    Kagawa, Tomoko
    Yoon, Hyungeun
    Atagi, Shinji
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] PD-L1 expression as a predictor of postoperative recurrence and the association between the PD-L1 expression and EGFR mutations in NSCLC
    Kensuke Kojima
    Tetsuki Sakamoto
    Takahiko Kasai
    Tomoko Kagawa
    Hyungeun Yoon
    Shinji Atagi
    Scientific Reports, 11
  • [7] Correlation between PD-L1 expression/TMB and immune cell infiltration: A pan-cancer study
    Xiong, J.
    Xiang, X.
    Li, J.
    Huang, S.
    Chen, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S287 - S288
  • [8] Pan-cancer analysis of programmed death-ligand 1 (PD-L1) amplifications
    Budczies, Jan
    Bockmayr, Michael
    Klauschen, Frederick
    Weichert, Wilko
    Denkert, Carsten
    Stenzinger, Albrecht
    CANCER RESEARCH, 2016, 76
  • [9] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [10] Efficacy of PD-1 or PD-L1 inhibitors and PD-L1 expression status in cancer: meta-analysis
    Shen, Xian
    Zhao, Bin
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
12345